ResearcherStanford MedicineNo recent work listed
Pamela L. Kunz
Matched on ORCID iD 0000-0003-1613-3919; OpenAlex author ID A5081606866. Sources: ClinicalTrials.gov.
Their work
- Papers
- 5
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2009: 1 trial · 2010: none · 2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper
Papers 5
- Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study. Co-author DOI 10.1097/mpa.0000000000001133↗
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. Co-author DOI 10.1016/j.ijrobp.2014.06.066↗
- Postradiotherapy CA19-9 kinetics correlate with outcomes in patients with pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000098↗
- Intensity-modulated radiotherapy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2011.09.035↗
- Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2010.05.006↗
Trials 1
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- George Albert Fisher · 4 shared papers, 2011–2018 · strength 0.18
- Paper Long-Term Survivors of Pancreatic Cancer: A California Population-Based Study. DOI 10.1097/mpa.0000000000001133↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Albert C. Koong · 4 shared papers, 2011–2014 · strength 0.14
- Paper Postradiotherapy CA19-9 kinetics correlate with outcomes in patients with pancreatic adenocarcinoma. DOI 10.1097/mpa.0000000000000098↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Daniel Tandel Chang · 4 shared papers, 2011–2014 · strength 0.14
- Paper Postradiotherapy CA19-9 kinetics correlate with outcomes in patients with pancreatic adenocarcinoma. DOI 10.1097/mpa.0000000000000098↗
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Adel Kardosh · 1 shared paper, 2018 · strength 0.10
- Christina A. Clarke Dur · 1 shared paper, 2018 · strength 0.10
- James M. Ford · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- Jeffrey Allen Norton · 3 shared papers, 2011–2014 · strength 0.08
- Paper Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. DOI 10.1016/j.ijrobp.2014.06.066↗
- Paper Intensity-modulated radiotherapy for pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2011.09.035↗
- Paper Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗
- George A. Poultsides · 2 shared papers, 2012–2014 · strength 0.06
- Brendan Christopher Visser · 2 shared papers, 2012–2014 · strength 0.06
- David Benjamin Shultz · 1 shared paper, 2014 · strength 0.05
- Aya Kamaya · 1 shared paper, 2014 · strength 0.04
- Erqi Liu Pollom · 1 shared paper, 2014 · strength 0.04
- Muthuraman Alagappan · 1 shared paper, 2014 · strength 0.04
- J.A. Abelson · 1 shared paper, 2012 · strength 0.03
- James Don Murphy · 1 shared paper, 2012 · strength 0.03
- Karyn A. Goodman · 1 shared paper, 2011 · strength 0.02
- Devin D. Schellenberg · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.